Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.
about
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular systemAcute migraine: Current treatment and emerging therapiesGastrointestinal Headache; a Narrative ReviewRamping it up: RAMP1 and the implications for migraineDiscovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of MigraineA new comorbidity model and the common pathological mechanisms of migraine and epilepsy.Evaluation of the changes in the nasal cavity during the migraine attack.CGRP receptor antagonists: an expanding drug class for acute migraine?Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteersExperimental migraine models and their relevance in migraine therapy.Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients.CGRP blockers in migraine therapy: where do they act?The blood-brain barrier in migraine treatment.CGRP receptor antagonists: A new frontier of anti-migraine medications.CGRP receptor antagonism and migraine.Calcitonin gene-related peptide: an update on the biology.Migraine pain: reflections against vasodilatation.Measurement of vasoactive neuropeptides in biological materials: problems and pitfalls from 30 years of experience and novel future approaches.Pearls and pitfalls in neural CGRP immunohistochemistry.Targeting CGRP: A New Era for Migraine Treatment.The Journey to Establish CGRP as a Migraine Target: A Retrospective View.BDNF and CGRP interaction: implications in migraine susceptibility.Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: results from a randomized study in patients with migraine.Lack of effect of the adenosine A1 receptor agonist, GR79236, on capsaicin-induced CGRP release in anaesthetized pigs.Association of Gastrointestinal Functional Disorders and Migraine Headache: a Population Base Study.Neurovascular mechanisms of migraine and cluster headache.Correlation between CGRP and migraine attacks.Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects. The Reykjavik Study.Mitogen-activated protein kinase pathways are involved in the upregulation of calcitonin gene-related peptide of rat trigeminal ganglion after organ culture.Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2.Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce MigrainePrevalence of Unexplained Upper Abdominal Symptoms in Patients with Migraine
P2860
Q24646305-40CCC7B7-D966-483C-ACA7-CBC1B30FBE93Q24654649-089154C8-2AF1-41BB-9F57-C5AC4B2A1D50Q28067564-49C62EC3-D5B1-401D-A138-AFA71ED863DCQ28266882-ACD451AC-08E1-4E32-A518-714216851855Q33630515-B21490E1-478B-4719-AC96-3F18B545FB8CQ33733178-22DE2DCF-BB95-475B-81B1-349A292DE7EBQ34167587-C6DB2745-5ACE-4494-9364-13909A096A98Q34637610-2C434556-0471-48F4-8103-BB429CB8986AQ36259595-609B84F3-5F28-449F-AD6E-0F3544B769F2Q36474260-A695AFBF-D93B-4FEB-B5EB-CDA194E805D0Q36662434-433BCF21-6617-4214-A2B7-1A8DBBA18DFEQ37002379-2903F78C-EABD-452F-A9ED-04F0560C6B07Q37252452-E53096CC-F251-4FDA-9A2C-37F68F12399DQ37362635-D293A645-A2F5-40C1-9B73-167339254B25Q37374122-3DFEDA2F-6490-4E68-AE60-D3E2AE8C54F5Q37478413-EEDEEF9A-E48E-4CAF-9B3A-5355C89CE105Q37508771-BFB829D7-0969-48F9-B369-C15177FF4353Q37798235-6F732C3B-6C54-468B-A6D9-A37B04ECBDACQ38106685-D281C30C-91B4-4BBC-902A-FFE0AE69B2B0Q38542176-C854341A-5815-4AD6-9008-6D90D7F72BB1Q38561443-AC218E62-C151-4697-AC9B-F0163877460FQ44354952-0B776B2F-72F4-4ADE-B5B8-26670564FC06Q46077794-386137A3-6BE7-4FDF-838F-49A4D95A6672Q46758893-08473BB8-3745-41D5-98D1-DA905BE57AC9Q47643511-FCD3387F-F44F-4471-8A87-346E5A364B83Q47758217-DA586806-B83A-48A3-964D-441A67905471Q49085369-60BAAD78-FAAE-4067-ADA5-45D7B26F01D6Q53258243-6AA940BA-D393-4DAB-B519-348550A52029Q54313316-4CEB5D14-9CCC-4AEC-8681-C6354C5DDBBAQ54410605-BBC59189-10E1-4E9D-929C-B96100C24D6DQ57024348-CCA1D071-D45A-4AFF-92AF-1AC7D59309D4Q57789585-06CB40BB-A882-4F55-A890-30E164059C1D
P2860
Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Blockade of CGRP receptors in ...... in the treatment of headache.
@ast
Blockade of CGRP receptors in ...... in the treatment of headache.
@en
type
label
Blockade of CGRP receptors in ...... in the treatment of headache.
@ast
Blockade of CGRP receptors in ...... in the treatment of headache.
@en
prefLabel
Blockade of CGRP receptors in ...... in the treatment of headache.
@ast
Blockade of CGRP receptors in ...... in the treatment of headache.
@en
P2860
P1433
P1476
Blockade of CGRP receptors in ...... t in the treatment of headache
@en
P2860
P304
P356
10.1111/J.1468-2982.2003.00719.X
P407
P577
2004-08-01T00:00:00Z